Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-126446
Filing Date
2024-11-13
Accepted
2024-11-13 16:53:33
Documents
18

Document Format Files

Seq Description Document Type Size
1 S-3 engene_form_s-3_nov_2024.htm S-3 400449
2 EX-4.1 engn-ex4_1.htm EX-4.1 981526
3 EX-5.1 engn-ex5_1.htm EX-5.1 39243
4 EX-5.2 engn-ex5_2.htm EX-5.2 24549
5 EX-23.1 engn-ex23_1.htm EX-23.1 3286
6 EX-23.2 engn-ex23_2.htm EX-23.2 4864
7 EX-99.1 engn-ex99_1.htm EX-99.1 435078
8 EX-99.2 engn-ex99_2.htm EX-99.2 635621
9 EX-99.3 engn-ex99_3.htm EX-99.3 370425
10 EX-FILING FEES engn-exfiling_fees.htm EX-FILING FEES 70476
11 GRAPHIC img93391562_0.jpg GRAPHIC 13415
12 GRAPHIC img93391562_1.jpg GRAPHIC 19311
13 GRAPHIC img93391562_2.jpg GRAPHIC 29572
14 GRAPHIC img94315083_0.jpg GRAPHIC 8155
15 GRAPHIC img94315083_1.jpg GRAPHIC 1140
16 GRAPHIC img94315083_2.jpg GRAPHIC 1148
17 GRAPHIC img167079210_0.jpg GRAPHIC 87857
18 GRAPHIC img167079210_1.jpg GRAPHIC 7738
  Complete submission text file 0000950170-24-126446.txt   3199514
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: S-3 | Act: 33 | File No.: 333-283201 | Film No.: 241455311
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)